Ticker > Company >

Dr. Agarwal''s Health share price

Dr. Agarwal''s Health Care Ltd.

NSE: AGARWALEYE BSE: 544350 SECTOR: Hospital & Healthcare Services  15.55 K   11   2

504.15
-3.60 (-0.71%)
BSE: Today, 04:01 PM

Price Summary

Today's High

₹ 515

Today's Low

₹ 488.05

52 Week High

₹ 512

52 Week Low

₹ 327.4

FinStar

Ownership Stable
Ownership strength is slightly missing the benchmark.
ValuationExpensive
The stock is at a premium valuation at this point.
EfficiencyPoor
The company seems highly inefficient in case of asset management.
FinancialsVery Stable
The company possesses stable growth history and manageable debt.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

15939.12 Cr.

Enterprise Value

15890.38 Cr.

No. of Shares

31.62 Cr.

P/E

726.86

P/B

8.24

Face Value

₹ 1

Div. Yield

0 %

Book Value (TTM)

₹  61.17

CASH

193.96 Cr.

DEBT

145.22 Cr.

Promoter Holding

32.42 %

EPS (TTM)

₹  0.69

Sales Growth

25.01%

ROE

1.39 %

ROCE

7.29%

Profit Growth

-7.97 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year25.01%
3 Year42.39%
5 Year33.31%

Profit Growth

1 Year-7.97%
3 Year156.72%
5 Year21.2%

ROE%

1 Year1.39%
3 Year4.13%
5 Year-2.41%

ROCE %

1 Year7.29%
3 Year9.02%
5 Year6.27%

Debt/Equity

0.0755

Price to Cash Flow

76.63

Interest Cover Ratio

1.4109

CFO/PAT (5 Yr. Avg.)

32.4234274731777

Shareholding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Jun 2025 32.42 0.00
Mar 2025 32.45 0.00
Investors List
* Figures given above are % of equity capital

 Strengths

  • The company has shown a good profit growth of 156.715928845361% for the Past 3 years.
  • The company has shown a good revenue growth of 42.3894810482351% for the Past 3 years.
  • The company has significantly decreased its debt by 186.76 Cr.
  • Company is virtually debt free.
  • The Company has been maintaining an effective average operating margins of 22.83196% in the last 5 years.
  • The company has an efficient Cash Conversion Cycle of -309.5867 days.
  • The company has a good cash flow management; CFO/PAT stands at 32.4234274731777.
  • Promoter stake has increased from 0% to 32.45% in the last 1 quarter.

 Limitations

  • Company has a poor ROE of 4.13306666666667% over the past 3 years.
  • The company is trading at a high PE of 726.86.
  • The company is trading at a high EV/EBITDA of 52.5198.

Quarterly Result (All Figures in Cr.)

PARTICULARS Dec 2024 Mar 2025 Jun 2025
Net Sales 267.93 281.02 301.72
Total Expenditure 203.22 207.59 234.92
Operating Profit 64.71 73.43 66.8
Other Income 10.48 26.93 13.04
Interest 23.38 20.9 19.32
Depreciation 39 42.2 44.21
Exceptional Items -0.71 -3.21 -0.71
Profit Before Tax 12.1 34.05 15.6
Tax 4.48 7.54 5.49
Profit After Tax 7.62 26.51 10.11
Adjusted EPS (Rs) 0.25 0.84 0.32

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Net Sales 232.24 361.59 597.64 835.06 1043.89
Total Expenditure 199.3 275.46 438.05 615.02 802.73
Operating Profit 32.94 86.13 159.59 220.04 241.16
Other Income 3.65 10.37 19.85 51.21 61.4
Interest 33.61 38.16 64.32 87.95 93.95
Depreciation 55.17 59.29 91.76 129.35 156.01
Exceptional Items 0 0 -29.2 -9.29 -14
Profit Before Tax -52.18 -0.95 -5.84 44.66 38.6
Tax 1.9 0.52 -37.43 20.83 16.67
Net Profit -54.08 -1.47 31.59 23.83 21.93
Adjusted EPS (Rs.) -2.63 -0.07 1.33 0.85 0.69

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity and Liabilities
Share Capital 6.86 6.86 7.93 9.36 31.59
Total Reserves 194.32 192.05 553.63 1217.85 1902.05
Borrowings 158.06 228.14 266.09 261.9 71.54
Other N/C liabilities 204.76 149.09 307.63 402.61 488.49
Current liabilities 78.86 116.31 213.3 276.94 341.84
Total Liabilities 642.87 692.45 1348.58 2168.66 2835.51
Assets
Net Block 386.91 367.15 906.94 1302.12 1591.3
Capital WIP 10.82 1.85 35.08 8.56 15.81
Intangible WIP 0 0 0 0 2.17
Investments 121.38 147.41 153.66 158.1 478.19
Loans & Advances 31.16 53.14 52.23 69.65 69.21
Other N/C Assets 8.52 0 0 0 47.92
Current Assets 84.08 122.9 200.67 630.23 630.91
Total Assets 642.87 692.45 1348.58 2168.66 2835.51
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Profit from operations -52.18 -0.95 -5.84 44.66 38.6
Adjustment 92.42 91.98 174.65 188.2 227.23
Changes in Assets & Liabilities 8.22 -9.94 -3.84 1.69 -64.17
Tax Paid -2.17 -2.79 -12.28 -12.97 6.34
Operating Cash Flow 46.29 78.3 152.69 221.58 208
Investing Cash Flow -26.45 -98.43 -435.57 -817.6 -577.46
Financing Cash Flow -21.12 40.16 315.94 570.41 374.08
Net Cash Flow -1.27 20.03 33.06 -25.61 4.62

Corporate Actions

Annual Reports

Title Link
Title Link
 No Annual reports exist for this company.Report us

Ratings & Research Reports

TYPE AGENCY Link
TYPE AGENCY Link
 No Credit and Research reports exist for this company.Report us
TYPE AGENCY Link
TYPE AGENCY Link
 No Research reports exist for this company.Report us

Concalls & Presentations

TYPE QUARTER Link
TYPE QUARTER Link
 Currently we do not have any Presentation and Concall related to this company.Report us
TYPE QUARTER Link
TYPE QUARTER Link
 Currently we do not have any Presentation related to this company.Report us

Company News

Dr. Agarwal''s Health Stock Price Analysis and Quick Research Report. Is Dr. Agarwal''s Health an attractive stock to invest in?

Stock investing requires careful analysis of financial data to determine a company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement, which can be time-consuming and cumbersome.

Examining a company's financial ratios is an easier way to determine its performance, which can help to make sense of the overwhelming amount of information in its financial statements. 

Here are a few indispensable ratios that should be a part of every investor’s research process, or, in simpler words, how to analyse Dr. Agarwal''s Health. 

  • PE ratio: Price to Earnings ratio, which indicates how much an investor is willing to pay for a share for every rupee of earnings. A general rule of thumb is that shares trading at a low P/E are undervalued (it depends on other factors too). Dr. Agarwal''s Health has a PE ratio of 723.832179930796 which is high and comparatively overvalued.

  • Return on Assets (ROA): Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. Dr. Agarwal''s Health has ROA of 0.8765% which is a bad sign for future performance. (Higher values are always desirable.)

  • Current ratio: The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. Dr. Agarwal''s Health has a Current ratio of 1.8456.

  • Return on equity: ROE measures the ability of a firm to generate profits from its shareholders' investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. Dr. Agarwal''s Health has a ROE of 1.3947%. (Higher is better)

  • Debt to equity ratio: It is a good metric to check out the capital structure along with its performance. Dr. Agarwal''s Health has a Debt to Equity ratio of 0.0755 which means that the company has low proportion of debt in its capital.

  • Sales growth: Dr. Agarwal''s Health has reported revenue growth of 25.0078% which is fair in relation to its growth and performance. 

  • Operating Margin: This will tell you about the operational efficiency of the company. The operating margin of Dr. Agarwal''s Health for the current financial year is 23.1020509823832%.

  • Dividend Yield: It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for Dr. Agarwal''s Health is Rs 0 and the yield is 0%.

  • Earnings Per Share: It tells us how much profit is allocated to to each outstanding share of a common stock. The latest EPS of Dr. Agarwal''s Health is Rs 0.6936. The higher the EPS, the better it is for investors. 

One can find all the Financial Ratios of Dr. Agarwal''s Health in Ticker for free. Also, one can get the intrinsic value of Dr. Agarwal''s Health by using Valuation Calculators, which are available with a Finology ONE subscription. 

Dr. Agarwal''s Health FAQs

Q1. What is Dr. Agarwal''s Health share price today?
Ans: The current share price of Dr. Agarwal''s Health is Rs 502.05.

Q2. What is the market capitalisation of Dr. Agarwal''s Health?
Ans: Dr. Agarwal''s Health has a market capitalisation of Rs 15872.730313185 Cr., calculated based on its latest share price.

Q3. What are the P/E and P/B ratios of Dr. Agarwal''s Health?
Ans: The PE ratio of Dr. Agarwal''s Health is 723.832179930796 and the P/B ratio of Dr. Agarwal''s Health is 8.20811214238185, showing how the stock is valued against its earnings and book value.

Q4. What is the 52-week high and low of Dr. Agarwal''s Health share?
Ans: The 52-week high share price of Dr. Agarwal''s Health is Rs 512.4, and the 52-week low share price of Dr. Agarwal''s Health is Rs 327.

Q5. Does Dr. Agarwal''s Health pay dividends?
Ans: Currently, Dr. Agarwal''s Health does not pay dividends. Dividend yield of Dr. Agarwal''s Health is around 0%.

Q6. What are the face value and book value of Dr. Agarwal''s Health shares?
Ans: The face value of Dr. Agarwal''s Health shares is Rs 1, while the book value per share of Dr. Agarwal''s Health is around Rs 61.1651. Face value is the nominal value set by the company, whereas book value reflects its accounting worth.

Q7. What is the debt of Dr. Agarwal''s Health?
Ans: Dr. Agarwal''s Health has a total debt of Rs 145.22 Cr., which affects investor sentiment and financial stability. 

Q8. What are the ROE and ROCE of Dr. Agarwal''s Health?
Ans: The ROE of Dr. Agarwal''s Health is 1.3947% and ROCE of Dr. Agarwal''s Health is 7.2869%. ROE shows how efficiently the company is generating profit from shareholders’ equity, while the ROCE is reflects how efficiently the company uses its capital to generate returns.

Q9. Is Dr. Agarwal''s Health a good buy for the long term?
Ans: The Dr. Agarwal''s Health long-term outlook depends on debt levels, earnings growth, and sector trends. If it sustains profits and manages debt well, it may be considered for long-term investment.

Q10. Is Dr. Agarwal''s Health undervalued or overvalued?
Ans: Based on valuation ratios like P/E, P/B, and EV/EBITDA, one can analyse whether the Dr. Agarwal''s Health appears undervalued or overvalued at current levels. You can check detailed valuation metrics and peer comparisons on Finology Ticker.

Q11. How to check Dr. Agarwal''s Health’s financials?
Ans: You can review Dr. Agarwal''s Health’s financial statements - including balance sheet, income statement, and quarterly results - on Finology Ticker.

Last Updated on:
Brief about Dr. Agarwal''s Health
X